George N. Minadakis - Genetic Mutations

Author Information

George N. Minadakis is affiliated with the Department of Bioinformatics at The Cyprus School of Molecular Medicine, The Cyprus Institute of Neurology & Genetics, Nicosia, Cyprus. His research primarily focuses on bioinformatics, genetics, and computational biology, with significant contributions to understanding genetic pathways and disease mechanisms, particularly in the context of SARS-CoV-2 and other complex diseases.

Research Contributions

George N. Minadakis has made substantial contributions to the fields of bioinformatics and genetics. His recent work includes the development of methods and tools for integrating multi-omics data, analyzing gene expression profiles, and understanding the virulence of specific mutations in SARS-CoV-2 strains. Noteworthy publications from 2020 and 2021 highlight his focus on systems bioinformatics, pathway analysis, and drug repurposing strategies against COVID-19. His research has provided insights into the molecular mechanisms underlying various diseases and has contributed to the identification of potential therapeutic targets.

Aliases

George N. Minadakis is also known by the aliases G. Minadakis and George Minadakis.

Publication and Citation Metrics

Metric	Value
Total Citations	679
h-index	17
Number of Papers	59

Publications:

Generalized linear models provide a measure of virulence for specific mutations in SARS-CoV-2 strains

DOI: 10.1371/journal.pone.0238665

Year: 2021

A Systems Bioinformatics Approach to Interconnect Biological Pathways.

DOI: 10.1007/978-1-0716-0822-7_17

Year: 2021

PathExNET: A tool for extracting pathway expression networks from gene expression statistics

DOI: 10.1016/j.csbj.2021.07.033

Year: 2021

Multi-omics data integration and network-based analysis drives a multiplex drug repurposing approach to a shortlist of candidate drugs against COVID-19

DOI: 10.1093/bib/bbab114

Year: 2021

PathWalks: identifying pathway communities using a disease-related map of integrated information

DOI: 10.1093/bioinformatics/btaa291

Year: 2020

Generalized linear models provide a measure of virulence for specific mutations in SARS-CoV-2 strains

DOI: 10.1101/2020.08.17.253484

Year: 2020

PathWalks: Identifying pathway communities using a disease-related map of integrated information

DOI: 10.1101/2020.01.27.921270

Year: 2020

ProtExA: A tool for post-processing proteomics data providing differential expression metrics, co-expression networks and functional analytics

DOI: 10.1016/j.csbj.2020.06.036

Year: 2020

Analyzing Gene Expression Profiles from Ataxia and Spasticity Phenotypes to Reveal Spastic Ataxia Related Pathways

DOI: 10.3390/ijms21186722

Year: 2020

Short-Term Foreshocks as Key Information for Mainshock Timing and Rupture: The Mw6.8 25 October 2018 Zakynthos Earthquake, Hellenic Subduction Zone

DOI: 10.3390/s20195681

Year: 2020

What is the Future of CFTR Gene Research?

Are There Any FDA-Approved Medications Specifically Designed for Genetic Mutations?

What is the Role of Neutral Mutations in Evolution?

What are Synonymous Codons?

How Does the Neutral Theory Affect Our Understanding of Genetic Diversity?

How is Cancer Genomics Studied?

Can Mutations be Repaired?

What Treatments are Available for Delta F508 Mutation?

How are Inherited Mutations Detected?

How Do Mutations Affect Genetic Coding?

Partnered Content Networks

Relevant Topics